Q3 2021 Innate Pharma SA Corporate Sales Call Transcript
Good afternoon, ladies and gentlemen, and welcome to Innate Pharma's Third Quarter 2021 Business Update Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded. (Operator Instructions) I will now hand over to Innate Pharma's Chairman of the Executive Board and Chief Executive Officer, Mondher Mahjoubi. Please go ahead, sir.
Thank you. Good morning, good afternoon, and welcome, everyone. This morning, we issued a press release providing a business update for the third quarter of 2021. I look forward to explaining the progress we made during the year to date as well as address some future goals and milestones. The press release and today's presentation are both available on the IR section of our website.
Please move to Slide #2. And before we start, I would like to remind you that we will make forward-looking statements regarding the financial outlook in addition to regulatory and product plan development. These statements are subject to
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |